Stockreport

IceCure Medical (ICCM) Submits Final Cryoablation Data to FDA [Yahoo! Finance]

IceCure Medical Ltd. - Ordinary Shares  (ICCM) 
PDF ProSense is designed to provide cryoablation, an outpatient technique that treats breast cancer in 20–40 minutes. It requests FDA approval to use cryoablation and adjuv [Read more]